FOSUN HEALTH Logo

Stomach Cancer Prevention

catalogue

Stomach Cancer Prevention

Stomach Cancer Prevention

Stomach cancer prevention has two proven components: removing Helicobacter pylori and finding precursor changes on endoscopy before they progress. Diet and smoking reduction lower risk further. What is not proven is doing more of it without a risk profile to guide the interval.

Who should be screened, and when

In countries where stomach cancer is common, screening by endoscopy reduces mortality from it, because endoscopy finds the disease at the stage where it is curable — often before it has caused a single symptom. Organised population programmes exist in Japan and Korea; in China, screening is offered according to risk, which places the responsibility for knowing your own profile on the patient and their physician.

Screening is reasonable to discuss if any of these apply: you are over 45–50 and live in a high-incidence region; you have a first-degree relative with gastric cancer; you have a known H. pylori infection; a previous biopsy showed atrophic gastritis or intestinal metaplasia; or you have persistent upper abdominal symptoms that have never been investigated with an endoscopy.

The value of a first endoscopy is not only what it finds. It establishes the state of the lining, photographs it, and gives the interval for the next one a factual basis rather than a habitual one.

Eradicating Helicobacter pylori

This is the single best-evidenced preventive action in stomach cancer. Eradicating the infection reduces the incidence of gastric cancer in infected people, and the benefit is greatest before atrophic gastritis and intestinal metaplasia have become established — which is why testing and treating is a public-health strategy in high-incidence countries, not merely a treatment for indigestion.

The practical sequence: test (breath test, stool antigen, or biopsy during endoscopy); treat with a defined course of combination therapy; confirm eradication afterwards, because treatment fails in a minority and a silent failure is worse than no treatment at all. Confirming success — usually a breath or stool test at least four weeks after finishing the course — is the step most often left out.

Where the stomach lining has already changed, eradication lowers the risk of progression but does not return the lining to normal, and surveillance continues on its own schedule. Treating the infection and following the metaplasia are two separate actions, and doing the first does not make the second optional.

How your risk profile is built

Surveillance intensity is set from four inputs, and they are worth assembling before an appointment rather than during one:

  • Family history — how many relatives, at what ages, and which side.
  • H. pylori status — current, previously eradicated, or never tested.
  • Findings on previous endoscopy and biopsy — normal, atrophic gastritis, intestinal metaplasia, dysplasia; with the extent and the stage of change.
  • Syndrome assessment — whether an inherited condition is suspected and whether genetic testing has been done.

From these, the interval follows. A normal endoscopy in a person without risk factors needs no fixed schedule. Extensive intestinal metaplasia is usually followed at intervals of one to three years. Dysplasia is not a screening question at all — it is a treatment question, handled by resection or by repeat endoscopy at short interval depending on its grade.

For people at high risk

A first-degree relative with gastric cancer, particularly more than one or diagnosed before 50, justifies starting endoscopy earlier than the general recommendation — commonly around 40, or ten years before the youngest diagnosis in the family, whichever comes first. Where a syndrome such as hereditary diffuse gastric cancer is identified, management is specific and considerably more aggressive, and it is decided with a genetics service rather than by a general screening rule.

High-risk also changes what is done with a normal result. A clean first endoscopy in a high-risk person is a baseline, not a discharge: it defines the lining at a known date and allows a change to be recognised at the next examination. Ask for the interval and the reason to be written into the report.

Diet and lifestyle: what is worth doing

The strongest dietary message is about what to reduce: salt overall, heavily salted and pickled foods, smoked and cured meats, processed meat. The second is about what to increase — fresh fruit and vegetables, which are consistently associated with lower risk. Both effects are population-level and take years; neither is a substitute for surveillance in someone with a precursor finding.

Stopping smoking lowers gastric cancer risk, particularly for cancers near the cardia, and the benefit accrues over years after quitting. Weight management and reflux control matter chiefly for gastro-oesophageal junction tumours. None of these actions needs a hospital; all of them compound over the same decades in which the precursor sequence progresses.

What prevention cannot do

Being honest about the limits matters more than enthusiasm. Diffuse-type cancer, particularly the hereditary form, does not follow the atrophy–metaplasia sequence and can arise in a stomach that looks endoscopically normal — which is why hereditary diffuse gastric cancer is managed by syndrome-specific rules rather than by surveillance intervals. Eradication reduces risk without abolishing it. And a normal endoscopy is a snapshot: it excludes disease on that day, at that resolution, not permanently.

Prevention also has a cost side. Repeating endoscopy more often than the risk justifies produces procedures, anxiety and occasional over-diagnosis without improving outcomes — which is why the interval, not the frequency, is the clinical decision.

A practical plan

  1. Test for H. pylori; treat if positive, and confirm eradication after the course.
  2. Write down your family history — who, what cancer, at what age.
  3. Have one baseline endoscopy if you have not had one and any of the risk reasons apply.
  4. If the lining is normal, follow the interval your risk profile dictates; if it shows atrophy or metaplasia, follow the surveillance interval for that finding.
  5. Reduce salt and preserved foods, eat fruit and vegetables, stop smoking — as background, not as the plan.

Our centres can arrange the endoscopy, the H. pylori testing and the surveillance interval in one visit, and if a lesion is found, the pathology and staging that follow are already in the same pathway. Send your history and any previous reports and we will tell you what interval applies to you.

Frequently Asked Questions

Can stomach cancer be prevented?

Partly, and the preventable share is substantial. Eradicating Helicobacter pylori reduces gastric cancer incidence; reducing salt and preserved foods and eating more fruit and vegetables lowers risk at population level; and endoscopic surveillance finds precursor changes and early cancers at the stage where they are curable. None of this prevents every case — hereditary diffuse gastric cancer in particular does not follow the usual sequence — so the honest formulation is that risk can be substantially lowered, and early detection does the rest.

How often should I have a gastroscopy for screening?

It depends on what the last one showed. A normal endoscopy in a person without risk factors does not need repeating on a fixed schedule. Atrophic gastritis or intestinal metaplasia is usually followed every one to three years depending on extent and severity. A first-degree relative with gastric cancer typically justifies starting around age 40 or ten years before the youngest family diagnosis. Dysplasia is not a screening interval at all — it is handled by resection or short-interval repeat endoscopy.

Does treating Helicobacter pylori undo the risk?

It lowers the risk; it does not erase it. Eradication prevents progression best when the stomach lining is still normal or only mildly inflamed, and once atrophic gastritis and intestinal metaplasia have developed, the changes persist and continue to carry risk even after the infection is gone. That is why eradication and surveillance are separate actions: the first addresses the cause, the second watches the changes it may already have left behind.

Are there supplements that prevent stomach cancer?

No supplement has been shown to prevent gastric cancer in a way that changes practice. Antioxidant supplements have been studied and have not produced a recommendation, and some trials raised separate concerns. The dietary evidence supports food patterns rather than pills: more fresh fruit and vegetables, less salt and preserved food. If a supplement is being taken for a deficiency, that is a different question and a legitimate one — but it is not cancer prevention.

Want a screening interval based on your own risk?

Tell us what your last gastroscopy showed and whether H. pylori was treated, and what you would like a second opinion on. Our team will review the reports and set out the surveillance or prevention plan that fits your risk — in writing.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*